Global Neurology Radiopharma Product Leader

GE HealthCare

6d•$193,600 - $290,400•Remote

About The Position

The Global Neurology Radiopharma Product Leader is responsible for defining and executing the global strategy for the Neurology molecular imaging portfolio, with an initial focus on Parkinson’s disease and Alzheimer’s disease. This role combines deep scientific and clinical understanding with strong strategic and commercial acumen to shape asset strategy, inform development priorities, and maximize the global value of the portfolio, with particular emphasis on the U.S. market. The leader will work across R&D, Clinical Development, Medical Affairs, Regulatory, Market Access, and Commercial teams to advance pipeline assets and support successful development, launch, and lifecycle management.

Requirements

Advanced degree in Life Sciences, Medicine, Pharmacy, Engineering, or a related field (e.g., PhD, MD, PharmD), with strong scientific credibility and strategic orientation.
Significant experience in product leadership, including milestone-based product development, launch readiness, and lifecycle management.
Deep expertise in neurology, radiopharmaceuticals, and molecular imaging, with strong knowledge of PET and SPECT.
Demonstrated ability to shape product and indication strategies in complex, cross-functional global environments.
Strong external credibility, with established relationships in the neurology and neuroimaging community, particularly in Alzheimer’s disease and related PET imaging spaces.
Experience working across global markets and influencing diverse stakeholders in a matrixed organization.
Experience launching diagnostic or imaging products in the U.S.; neurology-focused experience strongly preferred.

Responsibilities

Define and lead the global product strategy for neurology radiopharmaceutical assets, with a primary focus on Parkinson’s disease and Alzheimer’s disease.
Develop target product profiles grounded in unmet clinical need, customer insights, and evolving market requirements to inform development strategy and maximize asset value.
Build and evolve indication strategies for platform assets, prioritizing opportunities based on patient need, scientific rationale, commercial potential, and competitive dynamics.
Shape portfolio priorities and business cases to support investment decisions, development sequencing, and long term value creation across the neurology pipeline.
Lead the Integrated Evidence Generation Plan (IEGP) for key assets, prioritizing initiatives that accelerate adoption and demonstrate clinical and economic value.
Partner with Medical Affairs, Clinical Development, and Commercial teams to ensure evidence generation aligns with regulatory, reimbursement, and market adoption objectives.
Help define the value narrative for pipeline and in line assets, including differentiation, clinical utility, and relevance to healthcare systems and treatment pathways.
Oversee pre-launch, launch, and post-launch strategy across priority markets, ensuring strong cross functional alignment and execution readiness.
Identify opportunities for label expansion, new indications, and lifecycle optimization through real world evidence, customer insights, and market evolution.
Support key portfolio decisions by assessing trade-offs across indications, geographies, and development pathways.
Monitor global market trends, competitive activity, clinical practice developments, and unmet needs to inform strategic decisions and portfolio positioning.
Develop business cases for geographic expansion beyond the U.S., including assessment of market attractiveness, reimbursement considerations, clinical development requirements, and launch readiness.
Evaluate market maturity and health system readiness to support sequencing and prioritization of expansion opportunities.
Partner closely with Clinical Development to align clinical trial design, endpoints, and evidence plans with product strategy and commercial objectives.
Collaborate with Regulatory, Market Access, Medical Affairs, and Commercial teams to ensure integrated strategy development and execution across the product lifecycle.
Work with relevant stakeholders to support integration of PET imaging into neurology care pathways and broader clinical practice.
Build and maintain strong relationships with key opinion leaders, academic experts, and external stakeholders in neurology, neuroimaging, and nuclear medicine.
Leverage external networks and scientific engagement to inform strategy, strengthen market understanding, and support adoption of innovative molecular imaging solutions.